4th October 2008

New Appointments at NovaBiotics

We are delighted to welcome David Lawrence onto the board as Chairman. David brings expertise, energy, enthusiasm and a proven track record in leadership, strategy, business development and finance from roles at Tayside Flow Technologies, Acambis, GSK and Chiron as well as advising private companies. 

Dr. Ian Smith joins as an NXD.  Ian is a clinician by training and a founder of Synexus, one of the largest and most successful clinical research organisations for primary health care trials.  Ian sold the business last year but stays on as CMO.  We are very much looking forward to benefiting from Ian’s wealth of knowledge as regards the clinical development path.